Cargando…
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease
BACKGROUND AND PURPOSE: Acetyl-L-carnitine (ALC) is a widely used drug for various neurodegenerative diseases including dementia. The aim of the present study was to elucidate the efficacy of ALC in dementia patients with cerebrovascular disease (vascular cognitive impairment; VCI). METHODS: Fifty-s...
Autores principales: | Yang, YoungSoon, Choi, Hojin, Lee, Chan-Nyoung, Kim, Yong Bum, Kwak, Yong Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427993/ https://www.ncbi.nlm.nih.gov/pubmed/30906386 http://dx.doi.org/10.12779/dnd.2018.17.1.1 |
Ejemplares similares
-
Anxiety in Dementia
por: Kwak, Yong Tae, et al.
Publicado: (2017) -
Effects of acetyl‐L‐carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double‐blind, controlled trial
por: Li, Sheyu, et al.
Publicado: (2016) -
Improvement of Cognitive Function after Computer-Based Cognitive Training in Early Stage of Alzheimer's Dementia
por: Yang, YoungSoon, et al.
Publicado: (2017) -
Validation of a New Screening Tool for Dementia: The Simple Observation Checklist for Activities of Daily Living
por: Park, Jinse, et al.
Publicado: (2021) -
Cerebral Perfusion Changes after Acetyl-L-Carnitine Treatment in Early Alzheimer's Disease Using Single Photon Emission Computed Tomography
por: Jeong, Hyeonseok S., et al.
Publicado: (2017)